Skip to main content

Table 1 Demographic and pre-treatment clinical variables according to type of transfusions given.

From: A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]

 

ABO Matched, Leukoreduced

ABO Matched, Leukoreduced, Washed

P value by Mann Whitney or Fisher's Exact Test

N

18

25

 

Age

48 ± 23

47 ± 17

0.89

Male

9 (50%)

11 (44%)

0.76

ALL/AML

4/14

5/20

0.99

Antecedent Hematologic Disorder (MDS)

0 of 18 (0%)

3 of 25 (12%)

0.25

Favorable Risk Cytogenetics

1 (6%)

0 (0%)

0.09*

Standard Risk Cytogenetics

6 (33%)

7 (28%)

 

Poor Risk Cytogenetics

2 (11%)

11 (44%)

 

Unknown Cytogenetics

9 (50%)

7 (28%)

 

Admission Blast Count (×1000/μl)

25 ± 36

23 ± 41

0.59

  1. All data are mean ± 1 SD. MDS = myelodysplastic syndrome
  2. *For cytogenetics as a category overall